RxCheckUp
CGRP receptor antagonist (oral, small molecule)

Nurtec ODT (rimegepant) Letter of Medical Necessity

Nurtec ODT (rimegepant) is the only CGRP therapy approved for both acute and preventive migraine treatment. Prior authorization commonly requires documented triptan failure or contraindication and a migraine headache diary.

Generate a Nurtec ODT LMN — Free Trial →

FDA-Approved Indications

  • ● acute treatment of migraine
  • ● preventive treatment of episodic migraine

Why Nurtec ODT Prior Authorization Gets Denied

The most common denial reasons across major payers:

  1. 1. Two triptan trials not documented (step therapy)
  2. 2. Headache diary or migraine frequency not on file
  3. 3. Dual acute + preventive use not justified
  4. 4. Quantity limit exceeded

What to Include in a Nurtec ODT Letter of Medical Necessity

Document migraine diagnosis, monthly migraine days, MIDAS or HIT-6 disability score, prior acute treatments (triptans, NSAIDs) with documented inadequate response or contraindication, and the clinical rationale for dual-use oral CGRP antagonism when requesting both acute and preventive coverage.

Key clinical evidence to cite:

  • ✓ Study 301 (acute treatment)
  • ✓ Study 305 (preventive every-other-day dosing)
  • ✓ Long-term safety data

Relevant guidelines:

  • 📖 AHS Position Statement on CGRP Therapies
  • 📖 AAN Migraine Practice Guideline

Payers Covering Nurtec ODT

RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:

UnitedHealthcareAetnaCignaBCBSExpress Scripts

Nurtec ODT Prior Authorization FAQ

Why was my Nurtec ODT prior authorization denied?

The most common denial reasons for Nurtec ODT are: Two triptan trials not documented (step therapy); Headache diary or migraine frequency not on file; Dual acute + preventive use not justified; Quantity limit exceeded.

What should a Nurtec ODT Letter of Medical Necessity include?

Document migraine diagnosis, monthly migraine days, MIDAS or HIT-6 disability score, prior acute treatments (triptans, NSAIDs) with documented inadequate response or contraindication, and the clinical rationale for dual-use oral CGRP antagonism when requesting both acute and preventive coverage.

Which payers cover Nurtec ODT?

Nurtec ODT is covered by major US payers including UnitedHealthcare, Aetna, Cigna, BCBS, Express Scripts, though formulary tier and prior authorization criteria vary.